Avacta Group Share News (AVCT)

Avacta Says Collaborator Demonstrates Affimers With Luminex Platform

Avacta Snaps Up GlaxoSmithKline Alumni As Non-Executive

Avacta Raises GBP22 Million To Back Affirmers, IP Group Participates (ALLISS)

CORRECT: UPDATE: Avacta Says Annual Revenue To Meet Expectations As CFO Departs

UPDATE: Avacta Says Annual Revenue To Meet Expectations As CFO Departs

PROACTIS Appoints Avacta's Tim Sykes As Chief Financial Officer

Avacta Says Annual Revenue To Meet Expectations As CFO Steps Down

Avacta Group surges on Moderna deal

Shares in Avacta Group surged over 25% on Monday, after the proprietary diagnostic tools provider said it had reached a deal with biotech group Moderna Therapeutics. The London-listed company said its Life Sciences division had entered a collaboration, licensing and option agreement with US-based Mo

LONDON MIDDAY BRIEFING: BHP Billiton Hit As South32 Starts Trading

WINNERS & LOSERS: BHP Billiton Down As South32 Share Price Disappoints

BROKER RATINGS SUMMARY: Goldman Sachs Cuts BP To Sell From Neutral

Avacta Group Signs Licensing And Option Deal With Moderna Therapeutics

Avacta First-Half Loss Widens On Affimer Business Investment

Avacta Group Signs Commercial Partnership With PhoreMost

Avacta Sells It Optim Product To Unchained Labs In USD5 Million Deal